Immunogenicity 12666
Sample ID
3926
Response
Negative
Tumor Type
Melanoma
Gene Symbol
RPL19
Transcript ID
uc002hrq.1
HLA INFO
C*07:01
TCR INFO
No TCR info found!
Full length protein sequence (196 aa)
MSMLR
1
LQKRL
6
ASSVL
11
RCGKK
16
KVWLD
21
PNETN
26
EIANA
31
NSRQQ
36
IRKLI
41
KDGLI
46
IRKPV
51
TVHSR
56
ARCRK
61
NTLAR
66
RKGRH
71
MGIGK
76
RKGTA
81
NARMP
86
EKVTW
91
MRRMR
96
ILRRL
101
LRRYR
106
ESKKI
111
DRHMY
116
HSLYL
121
KVKGN
126
VFKNK
131
RILME
136
HIHKL
141
KADKA
146
RKKLL
151
ADQAE
156
ARRSK
161
TKEAR
166
KRREE
171
RLQAK
176
KEEII
181
KTLSK
186
EEETK
191
K
196
Mutation Information
DNA mutation:
None
Peptide Range:
157 ~ 181
Mut AA position:
169 (13 in Wild Type peptide)
Alignment
Wild Type:
"DQAEARRSKTKEARKRREERLQAKK
||||||||||||.||||||||||||
Mutant:
DQAEARRSKTKEGRKRREERLQAKK"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) RPL19
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay